Glow Lifetech Corp
Glow Lifetech Corp., a biotechnology company, focuses on producing nutraceutical and cannabinoid-based products. The company engages in the commercialization of plant-based MyCell technology delivery system; water-soluble ingredients; customized blends; powder-based Capsules, and market-ready products, as well as precision-dosed capsules. It has exclusive North American rights for the production,… Read more
Glow Lifetech Corp (GLWLF) - Total Liabilities
Latest total liabilities as of September 2025: $1.48 Million USD
Based on the latest financial reports, Glow Lifetech Corp (GLWLF) has total liabilities worth $1.48 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Glow Lifetech Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Glow Lifetech Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Glow Lifetech Corp Competitors by Total Liabilities
The table below lists competitors of Glow Lifetech Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Lupatech S.A
SA:LUPA3
|
Brazil | R$375.57 Million |
|
Nuintek Co.Ltd
KQ:012340
|
Korea | ₩58.56 Billion |
|
PT DFI Retail Nusantara Tbk
JK:HERO
|
Indonesia | Rp2.93 Trillion |
|
Shivam Autotech Limited
NSE:SHIVAMAUTO
|
India | ₹4.75 Billion |
|
Grounds Real Estate Development AG
XETRA:AMMN
|
Germany | €122.65 Million |
|
Oxbridge Re Holdings Ltd
NASDAQ:OXBR
|
USA | $1.98 Million |
|
Nocopi Technologies Inc
OTCQB:NNUP
|
USA | $429.20K |
|
ECARX Holdings Inc. Warrants
NASDAQ:ECXWW
|
USA | $5.70 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Glow Lifetech Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.16 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.67 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Glow Lifetech Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Glow Lifetech Corp (2019–2024)
The table below shows the annual total liabilities of Glow Lifetech Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.15 Million | -51.70% |
| 2023-12-31 | $2.38 Million | +108.44% |
| 2022-12-31 | $1.14 Million | +248.39% |
| 2021-12-31 | $328.03K | +3.95% |
| 2020-12-31 | $315.57K | +75.27% |
| 2019-12-31 | $180.05K | -- |